Abbott Laboratories (Pakistan) Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was PKR 13,805.92 million compared to PKR 11,771.16 million a year ago. Revenue was PKR 13,805.92 million compared to PKR 11,771.16 million a year ago.

Net loss was PKR 219.52 million compared to net income of PKR 1,441.78 million a year ago. Basic loss per share from continuing operations was PKR 2.24 compared to basic earnings per share from continuing operations of PKR 14.73 a year ago.